Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders
This study demonstrates a high prevalence of actionable CYP2D6 and CYP2C19 variants in the Central Indian population, underscoring the need for pharmacogenetic integration in psychiatric prescribing in Indian clinical settings, to enhance treatment efficacy and minimize adverse events.
Authors
- Santenna Chenchula (ORCID: https://orcid.org/0000-0001-7466-1037)
- Tamonud Modak (ORCID: https://orcid.org/0000-0002-0876-2881)
- Ratinder Jhaj (ORCID: https://orcid.org/0000-0002-3211-1122)
- R Rozatkar Abhijit
- Singh Jitendra
- Kumari Komal
- Atal Shubham
- Balakrishnan Sadasivam
- V. Satyaprakash
Institutions
- All India Institute of Medical Sciences Bhopal (IN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-11-25
- DOI
- https://doi.org/10.3389/fphar.2025.1697866
- Citations
- 1
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.56